IDO Don’ts: After Immunotherapy Failure, Experts Say Slow Down – Xconomy
Xconomy |
IDO Don'ts: After Immunotherapy Failure, Experts Say Slow Down
Xconomy They were a top choice to combine with the powerful but limited immunotherapies that have emerged this decade to fight many types of cancer. IDO inhibitors would broaden immunotherapy's reach, the thinking went. “Everything is starting to come together … |
